Skip to content
Toggle main navigation
PURPOSE logo
PURPOSE logo
  • Home
  • Events
  • Opportunities
  • News & Publications
  • T90/R90 HEAL Pain Cohort Program
  • Mobile App
  • About
  • Exhibit
  • Affiliate Networks
    • Music4Pain (U24)
    • ENSEMBLE Network (U24)
    • Pain Research Forum (PRF)
    • ForceNET (U24)
    • NeuronS_MATTR (U24)
    • SPINEWORK Network (U24)
    Log in
    Request to Join

    News & Publications

    Do you have news or publications to share with the PURPOSE Network? Submit your news below.

    Submit Your News or Publication
    All
    Acquired Cognitive Impairment
    Acupuncture
    Addiction
    Ageing
    Alcohol Use / Alcohol Use Disorder (AUD)
    Analgesics
    Analgesics, Topical
    Anatomy
    Anesthesia, General
    Anesthesia, Intravenous regional
    Anesthesia, Local
    Anesthesia, Spinal
    Animal Models
    Anxiety
    Arthritis, Rheumatoid
    See all

    Results (12)

    Orofacial neuropathic pain and enhanced excitability of non-nociceptive-like and nociceptive-like trigeminal Abeta-afferent neurons in mice following infraorbital nerve chronic constrictive injury

    Orofacial neuropathic pain and enhanced excitability of non-nociceptive-like and nociceptive-like trigeminal Abeta-afferent neurons in mice following infraorbital nerve chronic constrictive injury

    Mol Pain. 2026 Jan-Dec;22:17448069261499167. doi: 10.1177/17448069261499167. Epub 2026 Oct 20.ABSTRACTOrofacial neuropathic pain is a debilitating pain condition. It is poorly treated, partially due to an incomplete understanding of its underlying neurophysiological mechanisms. Orofacial neuropathic pain is often caused by injury or dysfunction of trigeminal nerve branches, including the infraorbi
    October 21, 2026
    Microglial CX3CR1 signaling mediates stress-induced pain behavior in mice

    Microglial CX3CR1 signaling mediates stress-induced pain behavior in mice

    Front Immunol. 2026 Jul 1;17:1869876. doi: 10.3389/fimmu.2026.1869876. eCollection 2026.ABSTRACTINTRODUCTION: Chronic primary pain conditions, including fibromyalgia, affect up to 10% of the population, yet their pathophysiology is unexplored and the treatment is insufficient. Chronic stress is a key etiological factor and is known to modulate microglial function, partly via the CX3CR1 fractalkine
    July 16, 2026
    Evaluation of Postblock Hypersensitivity Using Quantitative Sensory Testing before, during, and after Axillary Brachial Plexus Block Resolution in Healthy Volunteers

    Evaluation of Postblock Hypersensitivity Using Quantitative Sensory Testing before, during, and after Axillary Brachial Plexus Block Resolution in Healthy Volunteers

    Background:The problem of a sharp increase in pain after resolution of a nerve block, known as rebound pain, has been increasingly recognized. It is currently unknown whether rebound pain simply reflects the unmasking of untreated, residual surgical pain, or if it represents a de novo hyperalgesic state driven by a mechanistic resetting of pain thresholds in response to regional anesthesia. In thi
    July 15, 2026
    A-type potassium channels in pain signaling: Fundamental mechanisms and pathophysiological roles

    A-type potassium channels in pain signaling: Fundamental mechanisms and pathophysiological roles

    Pharmacol Ther. 2026 Jun 8:109052. doi: 10.1016/j.pharmthera.2026.109052. Online ahead of print.ABSTRACTPain is a major clinical challenge characterized by maladaptive changes in somatosensory processing, leading to persistent hypersensitivity and limited therapeutic options. Voltage-gated A-type potassium channels have emerged as key determinants of neuronal excitability in both peripheral and ce
    June 10, 2026
    Microglial Involvement in Inflammatory Pain Hypersensitivity in Adult Rats after Adolescent Morphine Exposure

    Microglial Involvement in Inflammatory Pain Hypersensitivity in Adult Rats after Adolescent Morphine Exposure

    Physiol Behav. 2026 Jun 6:115414. doi: 10.1016/j.physbeh.2026.115414. Online ahead of print.ABSTRACTBACKGROUND AND AIM: Adolescent morphine exposure (AME) is increasingly recognized as a risk factor for long-term alterations in pain processing, predisposing individuals to persistent pain in adulthood. Microglia are key regulators of neuroimmune signaling and central sensitization, yet their contri
    June 9, 2026
    Sustained Neuronal Stimulation Activates Paraventricular Thalamus Astrocytes for Chronicity of Neuropathic Pain in Mice

    Sustained Neuronal Stimulation Activates Paraventricular Thalamus Astrocytes for Chronicity of Neuropathic Pain in Mice

    Glia. 2026 Aug;74(8):e70183. doi: 10.1002/glia.70183.ABSTRACTCurrent treatments for chronic neuropathic pain are limited in efficacy, partly due to the complicated etiology of neuropathic pain chronicity. Ongoing nociceptive inputs from peripheral injuries lead to maladaptive alterations in the central nervous system during the transition from acute to chronic pain, which in turn contribute to the
    June 3, 2026
    New Strategy for Treating Visceral Pain: Enhancing Opioid Antinociception by Sigma-1 Receptor Inhibition

    New Strategy for Treating Visceral Pain: Enhancing Opioid Antinociception by Sigma-1 Receptor Inhibition

    J Pain. 2026 May 27:106329. doi: 10.1016/j.jpain.2026.106329. Online ahead of print.ABSTRACTVisceral pain remains a major clinical challenge, often resistant to conventional analgesics. Sigma-1 receptor (σ1R) antagonists enhance opioid antinociception in somatic and neuropathic pain, yet their role in visceral nociception remains unclear. Here we investigated whether σ1R blockade potentiates the a
    May 29, 2026
    A novel TCF12-MAVS signaling axis in astrocytes promotes vincristine-induced neuropathic pain in male mice

    A novel TCF12-MAVS signaling axis in astrocytes promotes vincristine-induced neuropathic pain in male mice

    Brain Behav Immun. 2026 May 20:106829. doi: 10.1016/j.bbi.2026.106829. Online ahead of print.ABSTRACTChemotherapy-induced neuropathic pain (CINP) can be triggered by microtubule-targeting agents, including plant-derived vinca alkaloids such as vincristine (VCR). In a male mouse model of VCR-induced neuropathic pain (VINP), mitochondrial antiviral signaling protein (MAVS) expression was upregulated
    May 22, 2026
    Wavelength dependence of acute, light-evoked recruitment of brainstem pain-modulating systems in female rats

    Wavelength dependence of acute, light-evoked recruitment of brainstem pain-modulating systems in female rats

    Neurobiol Pain. 2026 May 3;20:100217. doi: 10.1016/j.ynpai.2026.100217. eCollection 2026 Jul-Dec.ABSTRACTChronic pain states are often associated with sensory hypersensitivities, including acute sensitivity to light. White light exposure has been shown to activate a significant subset of pain-facilitating neurons and suppress firing of pain-inhibiting neurons in the rostral ventromedial medulla (R
    May 22, 2026
    CTRP3 alleviates neuropathic pain by improving mitochondrial biogenesis and mitochondrial unfolded protein response via spinal SIRT1 in rats

    CTRP3 alleviates neuropathic pain by improving mitochondrial biogenesis and mitochondrial unfolded protein response via spinal SIRT1 in rats

    Int J Mol Med. 2026 Jul;58(1):197. doi: 10.3892/ijmm.2026.5868. Epub 2026 May 22.ABSTRACTNeuropathic pain arises from an intricate network of interconnected pathophysiological mechanisms, yet the arsenal of effective therapeutic strategies remains frustratingly limited. Accumulating evidence has linked mitochondrial dysfunction to the progression of neuropathic pain. C1q‑tumor necrosis factor‑rela
    May 22, 2026
    EXPRESS: Metformin Exhibits Analgesic Activity in Neuronal Cell Models and CFA-Induced Inflammatory Pain in Mice

    EXPRESS: Metformin Exhibits Analgesic Activity in Neuronal Cell Models and CFA-Induced Inflammatory Pain in Mice

    Mol Pain. 2026 May 14:17448069261452893. doi: 10.1177/17448069261452893. Online ahead of print.ABSTRACTInflammatory pain is mediated by complex interactions between immune signaling and sensory neurons, with prostaglandin E2-dependent pathways playing a central role in nociceptive sensitization. Metformin, a first-line antidiabetic drug, has emerged as a potential non-opioid analgesic due to its p
    May 14, 2026
    JNK inhibition suppresses microglial NLRP3 activation and oxidative stress but unexpectedly worsens pain in diabetic neuropathy: insights from a combined in vitro and in vivo pharmacological study

    JNK inhibition suppresses microglial NLRP3 activation and oxidative stress but unexpectedly worsens pain in diabetic neuropathy: insights from a combined in vitro and in vivo pharmacological study

    Neurochem Int. 2026 May 4:106167. doi: 10.1016/j.neuint.2026.106167. Online ahead of print.ABSTRACTDiabetic neuropathy (DN) is driven by neuroinflammation and oxidative stress, with c-Jun N-terminal kinase (JNK) as a key mediator; however, the effects of JNK inhibition on neuropathic pain remain unclear. Therefore, we investigated the therapeutic potential of the JNK inhibitor SP600125 in a type 2
    May 7, 2026
    Contact
    Neurovations Education
    [email protected]

    United States

    PURPOSE@PainResearchers.com
    707-260-0848
    Links
    • NIH HEAL Initiative
    • Research in Pain Management